As deaths from an Ebola virus outbreak in the Democratic Republic of Congo and Uganda have risen above 80, the World Health ...

Novartis has reported new data to support its drive to expand the label of its radioligand therapy Pluvicto to include ...

Lead TroFuse-005 investigator Dr Domenica Lorusso of Humanitas University and Humanitas San Pio X in Milan, Italy. MSD's TROP2-targeting antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) ...

The FDA has approved AstraZeneca's aldosterone synthase inhibitor (ASI) – baxdrostat – for hard-to-treat hypertension, making ...

The turmoil at the FDA continues with the news that Tracy Beth Høeg has been fired as acting head of the FDA's Center for ...

Regeneron has reported that its fianlimab antibody targeting LAG-3, an immune checkpoint proposed as a cancer target, has missed the mark in a highly anticipated melanoma trial. The phase 3 trial was ...

Yet, tell the council you’ve moved and you may still need to inform the school, your GP, the DVLA, and a range of other ...

Germany's Merck KGaA is looking at making further acquisitions to boost its business, according to chief executive Belén Garijo. The CEO – who is due to step down next April after five years in the ...

Embattled UK Prime Minister Sir Keir Starmer has put changes to the health service on the legislative programme in today's ...

Bristol Myers Squibb has forged close ties with China's Hengrui Pharma, partnering across 13 programmes in oncology, ...

The Supreme Court of the US has ruled that the abortion pill mifepristone can continue to be prescribed remotely and delivered by mail-order, overruling an appeals court decision earlier this month.

In its second pipeline-expanding deal in the space of 24 hours, GSK has licensed rights to a drug for chronic obstructive pulmonary disease (COPD) from US biotech Empirico for $85 million upfront. The ...